Registro:

Referencias:

• Afonso, S., Rouvier Garay, V., Martínez, M., Molinari, A., Batlle, A., Oxidative stress induced by griseofulvine in mice liver (2001) Biochem. Soc. Trans., 30, pp. A72
• Brennan, M.J.W., Cantrill, R.C., The effect of delta-aminolaevulinic acid on the uptake and efflux of amino acid neurotransmitters in rat brain synaptosomes (1979) Journal of Neurochemistry, 33 (3), pp. 721-725. , DOI 10.1111/j.1471-4159.1979.tb05217.x
• Buzaleh, A.M., Vazquez, E., Batlle, A., Alterations in fluorinated ether anesthetics effects on heme metabolism following chronic ethanol consumption (1995) Gen. Pharmac., 26, pp. 1425-1429
• Buzaleh, A.M., Vázquez, E., Enríquez De Salamanca, R., Batlle, A., An overview on Anesthesia and Porphyrias (1997) Endocrinol. Metab., 4, pp. 267-279. , Review
• Buzaleh, A.M., Vazquez, E.S., Nunez, G., Batlle, A.M.D.C., Effect of chronic anesthesia on the drug-metabolizing enzyme system and heme pathway regulation (1997) General Pharmacology, 28 (4), pp. 577-582. , DOI 10.1016/S0306-3623(96)00245-5, PII S0306362396002455
• Buzaleh, A.M., Del Carmen Martinez, M., Del Carmen Batlle, A.M., Relevance of cytochrome P450 levels in the actions of enflurane and isoflurane in mice: Studies on the haem pathway (2000) Clinical and Experimental Pharmacology and Physiology, 27 (10), pp. 796-800. , DOI 10.1046/j.1440-1681.2000.03346.x
• Carlsson, M., Carlsson, A., Interactions between glutamatergic and monoaminergic systems within the basal ganglia - Implications for schizophrenia and Parkinson's disease (1990) Trends in Neurosciences, 13 (7), pp. 272-276
• Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634
• Davidson, M.D., Wilce, P., Shanley, B.C., Increased sensitivity of the hippocampus in ethanol-dependent rats to toxic effect of N-methyl-D-aspartic acid in vivo (1993) Brain Research, 606 (1), pp. 5-9. , DOI 10.1016/0006-8993(93)91562-7
• Demasi, M., Penatti, C.A.A., Delucia, R., Bechara, E.J.H., The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: Implications in neuropsychiatric manifestations in porphyrias (1996) Free Radical Biology and Medicine, 20 (3), pp. 291-299. , DOI 10.1016/0891-5849(95)02035-7
• Dodd, P.R., Beckmann, A.M., Davidson, M.S., Wilce, P.A., Glutamate-mediated transmission, alcohol, and alcoholism (2000) Neurochemistry International, 37 (5-6), pp. 509-533. , DOI 10.1016/S0197-0186(00)00061-9, PII S0197018600000619
• Emanuelli, T., Prauchner, C.A., Dacanal, J., Zeni, A., Reis, E.C., De Mello, C.F., De Souza, D.O., Intrastriatal administration of 5-aminolevulinic acid induces convulsions and body asymmetry through glutamatergic mechanisms (2000) Brain Research, 868 (1), pp. 88-94. , DOI 10.1016/S0006-8993(00)02327-1, PII S0006899300023271
• Emanuelli, T., Pagel, F.W., Porciuncula, L.O., Souza, D.O., Effects of 5-aminolevulinic acid on the glutamatergic neurotransmission (2003) Neurochemistry International, 42 (2), pp. 115-121. , DOI 10.1016/S0197-0186(02)00074-8, PII S0197018602000748
• Grant, K.A., Valverius, P., Hudspith, M., Tabakoff, B., Ethanol withdrawal seizures and the NMDA receptor complex (1990) European Journal of Pharmacology, 176 (3), pp. 289-296
• Gulya, K., Grant, K.A., Valverius, P., Hoffman, P.L., Tabakoff, B., Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal (1991) Brain Res., 547, pp. 129-134
• Hollmann, M., Heinemann, S., Cloned glutamate receptors (1994) Annual Review of Neuroscience, 17, pp. 31-108
• Hu, X., Ticku, M.K., Chronic ethanol treatment upregulates the NMDA receptor function and binding in mammalian cortical neurons (1995) Mol. Brain Res., 30, pp. 347-356
• Kalluri, H.S.G., Mehta, A.K., Ticku, M.K., Up-regulation of NMDA receptor subunits in rat brain following chronic ethanol treatment (1998) Molecular Brain Research, 58 (1-2), pp. 221-224. , DOI 10.1016/S0169-328X(98)00112-0, PII S0169328X98001120
• Kappas, A., Sassa, S., Galbraitte, R.A., Nordmann, Y., The Porphyrias (1995) The Metabolic Bases of Inherited Disease, 7th Edition, pp. 2103-2160. , Scriver, C.R., Beaudet, A.L. and Valle, D. (eds.), McGraw Hill, New York
• Lavandera, J.V., Batlle, A.M.D.C., Buzaleh, A.M., Metabolization of porphyrinogenic agents in brain: Involvement of the Phase I drug metabolizing system. a comparative study in liver and kidney (2007) Cellular and Molecular Neurobiology, 27 (6), pp. 717-729. , DOI 10.1007/s10571-007-9154-0
• Lowry, O., Rosebrough, N., Farr, A., Randall, R., Protein measurement with the folin-phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275
• Mayer, M.L., Westbrook, G.L., The physiology of excitatory amino acids in the vertebrate central nervous system (1987) Progress in Neurobiology, 28 (3), pp. 197-276. , DOI 10.1016/0301-0082(87)90011-6
• McDonald, J.W., Johnston, M.V., Physiological and pathophysiological roles of excitatory amino acids during cental nervous system development (1990) Brain Research Reviews, 15 (1), pp. 41-70. , DOI 10.1016/0165-0173(90)90011-C
• McLoughlin, J.L., Cantrill, R.C., The effect of delta-aminolaevulinic acid on the high affinity uptake of aspartic acid by rat brain synaptosomes (1984) General Pharmacology: Vascular System, 15 (6), pp. 553-555. , DOI 10.1016/0306-3623(84)90215-5
• Meldrum, B., Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease (1990) Trends in Pharmacological Sciences, 11 (9), pp. 379-387. , DOI 10.1016/0165-6147(90)90184-A
• Meldrum, B., Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease (1991) Trends in Pharmacological Sciences: The Pharmacology of Excitatory Amino Acids, a Special Report, pp. 54-62. , Lodge, D. and Collingridge, L. (eds.), Elsevier, Cambridge, UK
• Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N., Nakanishi, S., Molecular cloning and characterization of the rat NMDA receptor (1991) Nature, 354 (6348), pp. 31-37
• Navone, N., Buzaleh, A.M., Polo, C., Afonso, S., Vazquez, E., Batlle, A., The effect of griseofulvin on the heme pathway II. An exhaustive analysis during short and long-term challenge (1991) Gen. Pharmac., 22, pp. 1179-1183
• Peterson, C., Cotman, C.W., Strain-dependent decrease in glutamate binding to the N-methyl-D-aspartic acid receptor during aging (1989) Neuroscience Letters, 104 (3), pp. 309-313. , DOI 10.1016/0304-3940(89)90594-6
• Pierach, C.A., Edwards, P.S., Neurotoxicity of 5-aminolevulinic acid and porphobilinogen (1978) Exp. Neurol., 62, pp. 810-814
• Puy, H., Deybach, J.-C., Bogdan, A., Callebert, J., Baumgartner, M., Voisin, P., Nordmann, Y., Touitou, Y., Increased 5-aminolevulinic acid and decreased pineal melatonin production. a common event in acute porphyria studies in the rat (1996) Journal of Clinical Investigation, 97 (1), pp. 104-110
• Ranft, A., Kurz, J., Deuringer, M., Haseneder, R., Dodt, H.-U., Zieglgansberger, W., Kochs, E., Hapfelmeier, G., Isoflurane modulates glutamatergic and GABAergic neurotransmission in the amygdala (2004) European Journal of Neuroscience, 20 (5), pp. 1276-1280. , DOI 10.1111/j.1460-9568.2004.03603.x
• Reiter, R.J., Oxidative processes and antioxidative defense mechanisms in the aging brain (1995) FASEB J., 9, pp. 526-533
• Rodriguez, J.A., Buzaleh, A.M., Fossati, M., Azcurra, J., Batlle, A., The effects of some porphyrinogenic drugs on the brain cholinergic system (2002) Cell. Mol. Biol., 48, pp. 103-110
• Scherzer, C.R., Landwehrmeyer, G.B., Kerner, J.A., Counihan, T.J., Kosinski, C.M., Standaert, D.G., Daggett, L.P., Young, A.B., Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: Hippocampus and cortex (1998) Journal of Comparative Neurology, 390 (1), pp. 75-90. , DOI 10.1002/(SICI)1096-9861(19980105)390:1<75::AID-CNE7>3.0.CO;2-N
• Shanley, B.C., Neathling, A.C., Percy, V.A., Carstens, M., Neurochemical aspects of porphyria: Studies on the possible neurotoxicity of 5-aminolevulinic acid (1975) S. Afr. J. Lab. Clin. Med., 49, pp. 576-580
• Sonntag, W.E., Bennett, S.A., Khan, A.S., Thornton, P.L., Xu, X., Ingram, R.L., Brunso-Bechtold, J.K., Age and insulin-like growth factor-1 modulate N-methyl-D-aspartate receptor subtype expression in rats (2000) Brain Research Bulletin, 51 (4), pp. 331-338. , DOI 10.1016/S0361-9230(99)00259-2, PII S0361923099002592
• Tremwel, M.F., Anderson, K.J., Hunter, B.E., Stability of [3H]MK-801 binding sites following chronic ethanol consumption (1994) Alcoholism: Clinical and Experimental Research, 18 (4), pp. 1004-1008. , DOI 10.1111/j.1530-0277.1994.tb00073.x
• Trevisan, L., Fitzgerald, L.W., Brose, N., Gasic, G.P., Heinemann, S.F., Duman, R.S., Nestler, E.J., Chronic ingestion of ethanol up-regulates NMDAR1 receptor subunit immunoreactivity in rat hippocampus (1994) Journal of Neurochemistry, 62 (4), pp. 1635-1638
• Tsai, G., Coyle, J.T., The role of glutamatergic neurotransmission in the pathophysiology of alcoholism (1998) Annual Review of Medicine, 49, pp. 173-184. , DOI 10.1146/annurev.med.49.1.173
• Ulrichsen, J., Bech, B., Ebert, B., Diemer, N.H., Allerup, P., Hemmingsen, R., Glutamate and benzodiazepine receptor autoradiography in rat brain after repetition of alcohol dependence (1996) Psychopharmacology, 126 (1), pp. 31-41. , DOI 10.1007/BF02246408
• Villayandre, B.M., Paniagua, M.A., Fernandez-Lopez, A., Calvo, P., Effect of delta-aminolevulinic acid treatment on N-methyl-D-aspartate receptor at different ages in the rat brain (2005) Brain Research, 1061 (2), pp. 80-87. , DOI 10.1016/j.brainres.2005.08.001, PII S0006899305011510
• Wong, E.H.F., Kemp, J.A., Priestley, T., The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist (1986) Proceedings of the National Academy of Sciences of the United States of America, 83 (18), pp. 7104-7108. , DOI 10.1073/pnas.83.18.7104

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------